Abstract Purpose The Contrast Media Safety Committee (CMSC) of the European Society of
Urogenital Radiology (ESUR) has updated its 1999 guidelines on contrast medium-induced …

Drug-induced kidney disease occurs primarily in patients with underlying risk factors. A
number of factors enhance the vulnerability of the kidney to the nephrotoxic effects of drugs …

Objectives: This study was designed to evaluate whether the absence of coronary calcium
could rule out≥ 50% coronary stenosis or the need for revascularization. Background: The …

Purpose: To compare the nephrotoxicity of iso-osmolar iodixanol with that of nonionic low-
osmolar contrast media (CM)(LOCM) in randomized clinical trials. Materials and Methods …

Background—No direct comparisons exist of the renal tolerability of the low-osmolality
contrast medium iopamidol with that of the iso-osmolality contrast medium iodixanol in high …

Background: Based on a single clinical trial, it has been suggested that the contrast agent
iodixanol, which is isotonic to human plasma, may be less nephrotoxic than other nonionic …

Contrast-induced nephropathy (CIN) has been a hot topic during the last 5 years due its
association with increased morbidity and mortality. CIN is an important complication …

BACKGROUND: Iso-osmolar contrast medium iodixanol has been reported to be less
nephrotoxic than selected low-osmolar contrast media (LOCM) in chronic kidney disease …

Background: We performed a multicenter, double-blind, randomized, parallel-group study to
compare the renal effects of iomeprol-400 and iodixanol-320 in patients with preexisting …

Contrast-induced acute kidney injury (CI-AKI) is a serious complication that can affect
outcome and prognosis of patients undergoing percutaneous diagnostic and interventional …